About Gaurav Parmar, MD, MPH
Dr. Gaurav Parmar is a vascular medicine specialist at Massachusetts General Hospital and an Instructor of Medicine at Harvard Medical School. He serves as the Director of Vascular Medicine Outcomes Research, the Program Director of the Vascular Medicine Fellowship, and the Vascular Medicine Lead for the MGH Limb Evaluation, Assessment, and Preservation Program (LEAPP) at the MGH Peripheral Artery Disease (PAD) Center. Additionally, Dr. Parmar is the Interim Medical Director of VASCORE, the Vascular Imaging Core Laboratory at MGH, and Co-Medical Director of the MGH Anticoagulation Management Service. He is board-certified in Vascular Medicine by the American Board of Vascular Medicine. Dr. Parmar frequently presents at national and regional conferences, and he is the author of numerous publications, including book chapters and peer reviewed-publications, and serves as a reviewer for a variety of scientific journals, including the Vascular Medicine, official journal of the Society for Vascular Medicine. Dr Parmar has received multiple honors, including both teaching and residence awards. He is a Fellow of the Society for Vascular Medicine (FSVM), and the American College of Cardiology (FACC). He has served as a chair of the education committee of the Society for Vascular Medicine.
Dr. Parmar's research focuses on the epidemiology, outcomes, and disparities in cardiovascular diseases, particularly PAD. His significant contributions include demonstrating the benefits of statin therapy in PAD patients undergoing revascularization, improving limb salvage and mortality outcomes, which was featured in 50 Landmark Papers Every Vascular and Endovascular Surgeon Should Know (CRC Press, 2020). His recent work includes studies on high ankle-brachial index and long-term mortality, the impact of PAD and polyvascular disease in end-stage kidney disease and the influence of preexisting coronary artery disease on outcomes in diabetic patients after kidney transplant. Dr. Parmar has also investigated racial disparities in mortality rates over a 20-year period in individuals with PAD.
Clinical Interests:
- Acute and Chronic Venous Thromboembolic Diseases: DVT, PE, CTEPH
- Anticoagulation Management
- Arteriopathy/Fibromuscular Dysplasia (FMD)
- Cardiovascular Preventive medicine/ Nutrition in Medicine
- Carotid artery disease
- Chronic Venous Insufficiency/Varicose Veins
- Covid-19 Associated Thromboembolism
- Lower Extremity Peripheral Artery Disease (PAD)
- Lymphedema/Lipedema
- Non-surgical Aneurysms and Dissections
- Point-of-care Ultrasound (POCUS)
- Raynaud?s/Pernio-Chilblains/Acrocyanosis
- Renal/Mesenteric Artery Diseases
- Undifferentiated Leg Swelling and Ulcers
- Vascular Risk-Factors Mitigation
Treats:
- Adult
Languages:
- Gujarati, Hindi
Locations
Mass General Heart Center
55 Fruit St.
Boston, MA 02114
Phone: 781-487-2800
Mass General Vascular Center at Waltham
52 Second Ave.
Suite 2100
Waltham, MA 02451
Phone: 781-487-2800
Mass General Revere HealthCare Center
300 Ocean Ave.
Revere, MA 02151
Phone: 781-485-6140
Medical Education
- MBBS, Government Medical College Bhavnagar
- Residency, Baptist Outreach Services
- Fellowship, Massachusetts General Hospital
American Board Certifications
- Family Medicine, American Board of Family Medicine
- Registered Physician for Vascular Interpretation, APCA - Alliance for Physician Certification & Advancement
Accepted Insurance Plans
- Aetna
- Beech Street
- Blue Cross Blue Shield
- Blue Cross Blue Shield Medicare
- Cigna
- Commonwealth Care Alliance
- Coventry
- Fallon Health
- Harvard Pilgrim Health Care
- Humana
- Mass General Brigham Health Plan
- Medicaid CT
- Medicaid NH
- Medicaid RI
- Medicaid VT
- Medicare
- Medicare ACO
- Multiplan
- Senior Whole Health
- TriCare
- Tufts Health Plan
- United Health Care
- Wellpoint
- WellSense
- WellSense NH
Note: This provider may accept more insurance plans than shown; please call the practice to find out if your plan is accepted.
Research
Dr. Parmar's research interest focuses on epidemiology, outcomes, and disparities in cardiovascular diseases. He has served as the Science Director of the Outcomes Unit for the NIH-supported study, the Reasons for Geographic and Racial Disparities in Stroke-MI (REGARDS-MI), which is one of the largest cohort studies encompassing prospective tracking of over 30,000 participants from the conterminous U.S. Dr. Parmar was also the first to survey health care needs of the American Indian tribal members, preparing a 62-page report, which is the first to document the health status of Alabama Indians.
Publications
-
Selected publications:
Mehta H, Chan WC, Aday AW, Jones WS, Parmar GM, Hance K, Thors A, Alli A, Wiley M, Tadros P, Gupta K. Outcomes of peripheral artery disease and polyvascular disease in patients with end-stage kidney disease. J Vasc Surg. 2024 Jan 19:S0741-5214(24)00076-4. doi: 10.1016/j.jvs.2024.01.016. Epub ahead of print. PMID: 38244643.
Jiwani S, Chan WC, Majmundar M, Patel KN, Mehta H, Sharma A, Parmar G, Wiley M, Tadros P, Hockstad E, Yarlagadda SG, Gupta A, Gupta K. Impact of preexisting coronary artery and peripheral artery disease on outcomes in diabetic patients after kidney transplant. Vasc Med. 2023 Nov 7:1358863X231205574. doi: 10.1177/1358863X231205574. Epub ahead of print. PMID: 37936422.
Suarez Ferreira SP, Hall RP, Majumdar M, Goudot G, Jessula S, Bellomo T, Lee I, Kukreja N, Parmar G, Boada AE, Dua A. Atorvastatin Effect on Clopidogrel Efficacy in Patients with Peripheral Artery Disease. Ann Vasc Surg. 2023 Sep;95:74-79. doi: 10.1016/j.avsg.2023.05.023. Epub 2023 May 30. PMID: 37257642; PMCID: PMC10524645.
Dicks AB, Lakhter V, Elgendy IY, Schainfeld RM, Mohapatra A, Giri J, Weinberg MD, Weinberg I, Parmar G. Mortality differences by race over 20 years in individuals with peripheral artery disease. Vasc Med. 2023 Apr 3:1358863X231159947. doi: 10.1177/1358863X231159947. Epub ahead of print. PMID: 37010137.
Weinberg I, Parmar G. A Quick Fix for Better Walking? That's Probably a Bit of a Stretch. Cardiovasc Revasc Med. 2019 Aug;20(8):628-629. (https://pubmed.ncbi.nlm.nih.gov/31420071/)
Parmar GM, Novak Z, Spangler E, Patterson M, Passman MA, Beck AW, Pearce BJ. Statin use improves limb salvage after intervention for peripheral arterial disease. J Vasc Surg. 2019 Aug;70(2):539-546. (https://pubmed.ncbi.nlm.nih.gov/30718113/)
Shendre A, Parmar GM*, Dillon C, Beasley TM, Limdi NA. Influence of Age on Warfarin Dose, Anticoagulation Control, and Risk of Hemorrhage. Pharmacotherapy. 2018 Jun;38(6):588-596. (https://pubmed.ncbi.nlm.nih.gov/29393514/) (*co-first author)
Parmar GM, Lowman B, Combs BR, Taylor SM, Patterson MA, Passman MA, Jordan WD Jr. Effect of lipid-modifying drug therapy on survival after abdominal aortic aneurysm repair. J Vasc Surg. 2013 Aug;58(2):355-63. (https://pubmed.ncbi.nlm.nih.gov/23561430/)
Safford MM, Parmar G, Barasch CS, Halanych JH, Glasser SP, Goff DC, Prineas RJ, Brown TM. Hospital laboratory reporting may be a barrier to detection of 'microsize' myocardial infarction in the US: an observational study. BMC Health Serv Res. 2013 May 1;13:162. (https://pubmed.ncbi.nlm.nih.gov/23635044/)
Durant RW, Parmar G, Shuaib F, Le A, Brown TM, Roth DL, Hovater M, Halanych JH, Shikany JM, Prineas RJ, Samdarshi T, Safford MM. Awareness and Management of Chronic Disease, Insurance Status, and Health Professional Shortage Areas in the REasons for Geographic and Racial Differences in Stroke (REGARDS): A Cross-Sectional Study. BMC Health Serv Res. 2012 Jul 20;12(1):208. (https://pubmed.ncbi.nlm.nih.gov/22818296/)
Shuaib FM, Durant RW, Parmar G, Brown TM, Roth DL, Hovater M, Halanych JH, Shikany JM, Howard G, Safford MM. Awareness, treatment and control of hypertension, diabetes and hyperlipidemia and area-level mortality regions in the Reasons for Geographic and Racial Differences in Stroke (REGARDS) study. J Health Care Poor Underserved. 2012 May;23(2):903-21. (https://pubmed.ncbi.nlm.nih.gov/22643632/)
Quinney BE, Parmar GM, Nagre SB, Patterson M, Passman MA, Taylor S, Chambers J, Jordan WD. Long-term single institution comparison of endovascular aneurysm repair and open aortic aneurysm repair. J Vasc Surg. 2011 Dec;54(6):1592-8. (https://pubmed.ncbi.nlm.nih.gov/22137301/)
Brown TM, Parmar G, Durant RW, Halanych JH, Hovater M, Muntner P, Prineas RJ, Roth DL, Samdarshi TE, Safford MM. Health Professional Shortage Areas, Insurance Status, and Cardiovascular Disease Prevention in the Reasons for Geographic and Racial Differences in Stroke (REGARDS) Study. J Health Care Poor Underserved. 2011;22(4):1179-89. (https://pubmed.ncbi.nlm.nih.gov/22080702/)
Keith CJ Jr, Passman MA, Carignan MJ, Parmar GM, Nagre SB, Patterson MA, Taylor SM, Jordan WD Jr. Protocol implementation of selective postoperative lumbar spinal drainage after thoracic aortic endograft. J Vasc Surg. 2012 Jan;55(1):1-8; discussion 8. (https://pubmed.ncbi.nlm.nih.gov/21981799/)
Halanych JH, Shuaib F, Parmar G, Tanikella R, Howard VJ, Roth DL, Prineas RJ, Safford MM. Agreement on cause of death between proxies, death certificates, and clinician adjudicators in the Reasons for Geographic and Racial Differences in Stroke (REGARDS) study. Am J Epidemiol. 2011 Jun 1;173(11):1319-26. (https://pubmed.ncbi.nlm.nih.gov/21540327/)
Parmar G, Ghuge P, Halanych JH, Funkhouser E, Safford MM. Cardiovascular outcome ascertainment was similar using blinded and unblinded adjudicators in a national prospective study. J Clin Epidemiol. 2010 Oct;63 (10): 1159-63. (https://pubmed.ncbi.nlm.nih.gov/20430582/)
Pub Med URL: https://pubmed.ncbi.nlm.nih.gov/?term=gaurav+parmar